You are here
ACV meeting statement, meeting 19, 3 February 2021
Advisory Committee on Vaccines
Section A: Submissions for registration
The committee provided advice on one application to register a new vaccine.
Further details of the ACV discussion and advice associated with these pre-market items may be released within the Australian Public Assessment Report (AusPAR). Please note that there is a delay between when an application is considered by the ACV and the publication of the AusPAR. To browse all AusPARs see AusPAR search.
Section B: Safety
The committee provided further advice and endorsed the COVID-19 Vaccine Pharmacovigilance Plan, which had been amended following the ACV meeting 16 held 30 September 2020.